Jan 17 2025 This Week in Cardiology

Renal denervation, the obesity paradox, JACC and the FINEARTS trial of finerenone in HFpEF, a setback for a PFA system, and coffee are the topics Jon Mandrola, MD, covers this week.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
www.medscape.c...
I. RDN

• CMS www.cms.gov/me...
• Messerli doi.org/10.101...
• Filippone doi.org/10.101...
II. Finerenone

• FINEHEARTS -HF NEJM www.nejm.org/d...
• FIDELIO-DKD www.nejm.org/d...
• FIGARO-DKD www.nejm.org/d...
• Why Have We Not Been Able to Demonstrate Reduced Mortality in Patients With HFmrEF/HFpEF? doi.org/10.101...
• Regional Variation TOPCAT www.ahajournal...
• Time from WHF Subanalysis doi.org/10.101...
• REDEFINE - clinicaltrials...
• Health status paper doi.org/10.101...
• Obesity subanalysis doi.org/10.101...
• Kidney outcomes www.sciencedir...
• Kidney outcomes 2 doi.org/10.101...
• Kaul editorial doi.org/10.101...
III. PFA Setback
J&J Halts Varipulse Field Ablation for AFib
www.medscape.c...
IV. Coffee
Stop the Coffee Studies www.medscape.c...

• Coffee drinking timing and mortality in US adults
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. www.medscape.c...
Questions or feedback, please contact [e-mail]